CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 150 filers reported holding CYTOKINETICS INC in Q1 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842,556 | -67.4% | 28,600 | -63.9% | 0.00% | -77.8% |
| Q2 2023 | $2,587,516 | -74.4% | 79,323 | -64.0% | 0.01% | -95.1% |
| Q4 2022 | $10,103,493 | +79.5% | 220,504 | +89.9% | 0.18% | +70.4% |
| Q3 2022 | $5,628,000 | +68.8% | 116,144 | +36.9% | 0.11% | +17.4% |
| Q2 2022 | $3,334,000 | +15.7% | 84,860 | +8.4% | 0.09% | +19.5% |
| Q1 2022 | $2,881,000 | +602.7% | 78,280 | +125.5% | 0.08% | -15.4% |
| Q1 2020 | $410,000 | +16.8% | 34,715 | +4.7% | 0.09% | +295.7% |
| Q4 2019 | $351,000 | +61.0% | 33,150 | +70.9% | 0.02% | -4.2% |
| Q2 2019 | $218,000 | – | 19,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |